Peptide merchant account fees explained for 2026

A peptide operator sent us a quote last month that read 2.9% and a fee schedule that ran to four pages. By the time we added the monthly minimum, the gateway fee, the per-transaction dime, the 12% rolling reserve, and the early termination clause, the real number was closer to 4.4% with 12% of revenue parked for six months. That gap between the headline rate and the effective rate is where peptide operators lose money they never see on a statement line. This guide breaks down every fee on a peptide merchant account in 2026, with real numbers, so you can read a quote the way an underwriter does. We orchestrate on top of these accounts, so we have no reason to soften the math.

The two numbers that matter: effective rate and held reserve

Forget the quoted rate. The number that matters is your effective rate: total fees for the month divided by total processing volume. That single figure rolls up interchange, markup, per-transaction fees, monthly fees, and assessments into one honest percentage.

The second number is the held reserve, which is not a fee at all but is just as real to your cash position. A 12% rolling reserve on a 180-day hold means 12% of every dollar you process sits frozen for six months. You earn it back, but it is gone from working capital today. Operators who only compare quoted rates miss the larger of the two costs.

Interchange: the part nobody marks up honestly

Interchange is the fee the card networks pay to the customer issuing bank, and it is the same for everyone. For card-not-present credit transactions, which is most peptide ecommerce, interchange runs roughly 1.65 to 2.60% plus about $0.10 per transaction. See the interchange entry for the full mechanics.

This is the floor. No processor sets it, none can discount it, and an honest provider passes it through at cost. multiflow does not mark up interchange, and you should be suspicious of anyone who quotes a flat blended rate so low it implies they are eating interchange, because they are not. They are recovering it elsewhere in the schedule.

Markup: where the processor actually makes money

On top of interchange sits the markup, and on a high-risk peptide account that markup is wider than on a low-risk supplement store. The honest pricing model is interchange-plus: interchange at cost plus a stated markup, so you can see exactly what the processor charges. A blended or tiered quote hides the markup inside a single percentage, which is why a 2.9% blended quote almost always costs more than a 1.0% interchange-plus markup once you do the arithmetic.

For peptides, expect a markup that lands you at a 3.5 to 4.5% effective rate single-brand at a specialist ISO. multiflow runs 5.5 to 7.5% per transaction plus setup, which only beats the single-brand math once you are at three or more brands and reconciliation overhead is the real cost.

Reserves: the largest cost on the page

For a first-year peptide account, plan on a 10 to 15% rolling reserve held 180 days. On $100,000 of monthly volume at 12%, that is $12,000 added to the held balance every month until the rolling window fills, after which old reserve releases as new accrues. Some acquirers use an upfront reserve instead, taking a lump sum at onboarding. Know which structure you are signing.

The reserve is negotiable over time. After six to twelve months of clean processing under the thresholds, ask for a step-down. Acquirers expect that conversation; the ones who refuse to ever revisit it are telling you something.

The fees that hide in the schedule

• Setup fee. $250 to $1,000 common on high-risk peptide accounts. multiflow charges setup because the parent-account build is real work.
• Gateway fee. Authorize.net or NMI monthly, roughly $20 to $35 plus a per-transaction cent or two on top of interchange.
• Monthly minimum. A floor you pay even in a slow month, often $25 to $50.
• PCI fee. Recurring charge tied to maintaining PCI-DSS 4.0.1 compliance, sometimes bundled, sometimes a line item.
• Early termination fee. $250 to $500 on a 2 to 3 year contract. Negotiate this down or out before you sign, because it is the clause that traps unhappy operators.
• Chargeback fee. $15 to $40 per dispute, charged whether you win or lose the representment.

A worked example

The effective rate is 4.1%, not the 2.9% the quote led with, and $12,000 of your cash is parked. That is the picture an underwriter sees and the one you should price against.

The assessments and incidental fees nobody quotes

Below interchange and above the markup sits a thin layer of card-network assessments that no processor can discount and most quotes never mention. They are small individually and real in aggregate.

• Network assessment. Roughly 0.13 to 0.15% of volume to Visa and Mastercard, passed through on top of interchange.
• Cross-border fee. If an international customer pays a US peptide store, the network adds roughly 0.4 to 1.0% on that transaction. Peptide stores selling to Canada, the UK, or Australia carry more of this than they expect.
• NABU / APF / acquirer fees. A few cents per authorization that the network charges the acquirer and the acquirer passes to you.
• Integrity and misuse fees. The Visa integrity fee hits transactions that miss data-quality requirements, and unrefunded authorizations or late settlements draw misuse charges. Clean integrations avoid most of these.

None of these are negotiable and none should be marked up. What you want from a processor is honest pass-through, not a flat blended number that buries them. When a quote cannot show you these lines, it is not that the fees are gone; it is that they are folded into a margin you cannot see.

Chargeback fees: the line that scales with your risk

A single chargeback on a peptide account costs more than the disputed sale. You pay a per-dispute fee of $15 to $40 whether you win the representment or lose it, you lose the goods if they already shipped, and a cluster of disputes can trip a reserve increase or a threshold review. The fee is the small part.

Run the arithmetic on a $120 peptide order that disputes. You refund or lose the $120, you eat a $25 chargeback fee, you spend staff time on representment, and if your chargeback ratio drifts toward the 0.9% Visa or 1.0% Mastercard line, the acquirer raises your reserve, which costs you far more than the dispute did. The cheapest dispute is the one a clear billing descriptor prevented before it started. Fee schedules treat chargebacks as a flat per-event cost; underwriters treat them as a leading indicator, and so should you.

Where multi-brand changes the math

Every separate peptide brand on its own merchant account multiplies the fixed fees: another setup, another gateway, another monthly minimum, another reserve to track, another statement to reconcile. At one or two brands the per-brand specialist-ISO rate of 3.5 to 4.5% wins easily. Somewhere around three to five brands the fixed-fee duplication and the reconciliation labor flip the math, and a single parent account at a higher per-transaction rate can cost less in total. We lay out that crossover in the true cost of multiple MIDs piece, on the peptide operator page, and in how it works.

Put the duplicated fixed costs side by side and the crossover stops being abstract. The table below holds the variable percentage roughly equal and isolates only the fixed and labor costs that repeat per account.

The visible line, the per-transaction rate, favors the separate accounts. Everything else on the page favors consolidation once the count of brands climbs. Whether the trade clears depends on your volume per brand: at high volume per brand the percentage difference dominates and you stay separate; at modest volume across many brands the fixed-fee duplication wins, and the parent account is cheaper in total.

Work a concrete case. Three peptide brands at $30,000 monthly each, $90,000 total. On separate accounts at 4.0% you pay about $3,600 in percentage fees plus three gateways, three minimums, and the bookkeeper days to reconcile three statements. On a parent account at 6.0% you pay about $5,400 in percentage fees but carry one gateway, one minimum, one ledger, and one reserve pool. The $1,800 monthly percentage gap is real, and at this volume the separate accounts still win on pure cost. Now run the same three brands at $8,000 each: the percentage gap shrinks to a few hundred dollars a month while the fixed-fee and labor duplication stays fixed, and consolidation pulls ahead. The crossover is not a brand count; it is a volume-per-brand number, and you have to run yours.

How to read your own statement

Pull last month, divide total fees by total volume, and write down the effective rate. Then add the held reserve as a separate line so you see the full cash impact. Compare that number, not the quoted rate, against any new offer. If you want a second set of eyes, our guide on auditing a peptide merchant statement walks through it line by line.

If you are running several peptide brands and are not sure whether your current fee stack is the cheapest honest option, send us the 12-question application. We will run your real numbers and tell you whether consolidating helps or whether you are already on the right setup. No hard pull, no pitch if it does not fit.